Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.75 CNY
−328.96 M CNY
111.08 M CNY
360.81 M
About FRONTIER BIOTECHNOLOGIES INC.
Sector
Industry
CEO
Chang Jin Wang
Website
Headquarters
Nanjing
Founded
2013
ISIN
CNE100005XF5
FIGI
BBG00PZ7WBM6
Frontier Biotechnologies, Inc. engages in the research, development, production, and sale of medicines. It offers hypercholesterolemia treatment, broadly neutralising antibody, and transdermal patch for musculoskeletal pain. The company was founded by Dong Xie, Chang Jin Wang and Rong Jian Lu on January 15, 2013 and is headquartered in Nanjing, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688221 is 7.99 CNY — it hasn't changed in the past 24 hours. Watch FRONTIER BIOTECHNOLOGIES INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange FRONTIER BIOTECHNOLOGIES INC. stocks are traded under the ticker 688221.
688221 stock has risen by 7.56% compared to the previous week, the month change is a 23.87% rise, over the last year FRONTIER BIOTECHNOLOGIES INC. has showed a −27.63% decrease.
688221 reached its all-time high on Oct 28, 2020 with the price of 35.53 CNY, and its all-time low was 4.48 CNY and was reached on Sep 18, 2024. View more price dynamics on 688221 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688221 stock is 8.23% volatile and has beta coefficient of 1.48. Track FRONTIER BIOTECHNOLOGIES INC. stock price on the chart and check out the list of the most volatile stocks — is FRONTIER BIOTECHNOLOGIES INC. there?
Today FRONTIER BIOTECHNOLOGIES INC. has the market capitalization of 2.88 B, it has increased by 3.72% over the last week.
Yes, you can track FRONTIER BIOTECHNOLOGIES INC. financials in yearly and quarterly reports right on TradingView.
FRONTIER BIOTECHNOLOGIES INC. is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
688221 net income for the last quarter is −33.00 M CNY, while the quarter before that showed −104.75 M CNY of net income which accounts for 68.50% change. Track more FRONTIER BIOTECHNOLOGIES INC. financial stats to get the full picture.
No, 688221 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 27, 2024, the company has 395.00 employees. See our rating of the largest employees — is FRONTIER BIOTECHNOLOGIES INC. on this list?
Like other stocks, 688221 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FRONTIER BIOTECHNOLOGIES INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FRONTIER BIOTECHNOLOGIES INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FRONTIER BIOTECHNOLOGIES INC. stock shows the sell signal. See more of FRONTIER BIOTECHNOLOGIES INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.